Carvedilol affects the physiological and behavioral response to smoked cocaine in humans

Drug and Alcohol Dependence

Volumn 60, Issue 1, 2000, Pages 69-76

  Sofuoglu, Mehmet ^a   Brown, Scott ^a   Babb, David A ^a   Pentel, Paul R ^a   Hatsukami, Dorothy K ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Adrenergic receptors; Cardiovascular effects; Carvedilol; Cocaine; Self administration

Indexed keywords

ADRENERGIC RECEPTOR; ADRENERGIC RECEPTOR BLOCKING AGENT; CARVEDILOL; COCAINE; PLACEBO;

ADULT; ARTICLE; BEHAVIOR; CARDIOVASCULAR EFFECT; CLINICAL ARTICLE; CLINICAL TRIAL; CROSSOVER PROCEDURE; DIASTOLIC BLOOD PRESSURE; DOUBLE BLIND PROCEDURE; DRUG SELF ADMINISTRATION; FEMALE; HEART RATE; HUMAN; MALE; NORADRENERGIC SYSTEM; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE;

EID: 0343183991     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0376-8716(00)80009-5     Document Type: Article

References (33)

1. Berthold C.W.d., Gonzales R.A., Moerschbaecher J.M. Prazosin attenuates the effects of cocaine on motor activity but not on schedule-controlled behavior in the rat. Pharmacol. Biochem. Behav. 43:1992;111-115.
2. Bessen H.A. Treatment of cocaine toxicity. Ann. Emerg. Med. 16:1987;922.
3. Boehrer J.D., Moliterno D.J., Willard J.E., Hillis L.D., Lange R.A. Influence of labetalol on cocaine-induced coronary vasoconstriction in humans. Am. J. Med. 94:1993;608-610.
4. Bremner J.D., Krystal J.H., Southwick S.M., Charney D.S. Noradrenergic mechanisms in stress and anxiety: I. Preclinical studies. Synapse. 23:1996;28-38.
5. Cahill L., McGaugh J.L. Modulation of memory storage. Curr. Opin. Neurobiol. 6:1996;237-242.
6. Chiueh C.C., Kopin I.J. Centrally mediated release by cocaine of endogenous epinephrine and norepinephrine from the sympathoadrenal medullary system of unanesthetized rats. J. Pharmacol. Exp. Ther. 205:1978;148-154.
7. Dunn C.J., Lea A.P., Wagstaff A.J. Carvedilol. A reappraisal of its pharmacological properties and therapeutic use in cardiovascular disorders. Drugs. 54:1997;161-185.
8. Dusenberry S.J., Hicks M.J., Mariani P.J. Labetalol treatment of cocaine toxicity. Ann. Emerg. Med. 16:1987;235.
9. Florin S.M., Kuczenski R., Segal D.S. Regional extracellular norepinephrine responses to amphetamine and cocaine and effects of clonidine pretreatment. Brain Res. 654:1994;53-62.
10. Frishman W.H. Carvedilol. N. Engl. J. Med. 339:1998;1759-1765.
11. Gay G.R., Loper K.A. The use of labetalol in the management of cocaine crisis. Ann. Emerg. Med. 17:1988;282-283.
12. Hadfield M.G. Cocaine. Selective regional effects on central monoamines. Mol. Neurobiol. 11:1995;47-53.
13. Harris G.C., Aston-Jones G. Beta-adrenergic antagonists attenuate withdrawal anxiety in cocaine- and morphine-dependent rats. Psychopharmacology. 113:1993;131-136.
14. Harris G.C., Hedaya M.A., Pan W.J., Kalivas P. Beta-adrenergic antagonism alters the behavioral and neurochemical responses to cocaine. Neuropsychopharmacology. 14:1996;195-204.
15. Hatsukami D., Keenan R., Carroll M., Colon E., Geiske D., Wilson B., Huber M. A method for delivery of precise doses of smoked cocaine-base to humans. Pharmacol. Biochem. Behav. 36:1990;1-7.
16. Hatsukami D.K., Pentel P.R., Glass J., Nelson R., Brauer L.H., Crosby R., Hanson K. Methodological issues in the administration of multiple doses of smoked cocaine-base in humans. Pharmacol. Biochem. Behav. 47:1994a;531-540.
17. Hatsukami D.K., Thompson T.N., Pentel P.R., Flygare B.K., Caroll M.E. Self-administration of smoked cocaine. Exp. Clin. Psychopharmacol. 2:1994b;115-125.
18. Johanson C.E., Barrett J.E. The discriminative stimulus effects of cocaine in pigeons. J. Pharmacol. Exp. Ther. 267:1993;1-8.
19. Kampman K.M., Rukstalis M., Ehrman R., McGinnis D.E., Gariti P., Volpicelli J.R., Pettinati H., O'Brien C.P. Open trials as a method of prioritizing medications for inclusion in controlled trials for cocaine dependence. Addict Behav. 24:1999;287-291.
20. Karch S.B. Managing cocaine crisis. Ann. Emerg. Med. 18:1989;228-230.
21. Kenny D., Pagel P.S., Warltier D.C. Attenuation of the systemic and coronary hemodynamic effects of cocaine in conscious dogs: propranolol versus labetalol. Basic Res. Cardiol. 87:1992;465-477.
22. Kiritsy-Roy J.A., Halter J.B., Gordon S.M., Smith M.J., Terry L.C. Role of the central nervous system in hemodynamic and sympathoadrenal responses to cocaine in rats. J. Pharmacol. Exp. Ther. 255:1990;154-160.
23. Lange R.A., Cigarroa R.G., Flores E.D., McBride W., Kim A.S., Wells P.J., Bedotto J.B., Danziger R.S., Hillis L.D. Potentiation of cocaine-induced coronary vasoconstriction by beta-adrenergic blockade. Ann. Intern. Med. 112:1990;897-903.
24. Leikin J.B. Cocaine and beta-adrenergic blockers: a remarriage after a decade-long divorce. Crit. Care Med. 27:1999;688-689.
25. Messerli F.H. Cardiovascular Drug Therapy. 1996;Saunders, Philadelphia, PA.
26. Morgan T. Clinical pharmacokinetics and pharmacodynamics of carvedilol. Clin. Pharmacokinet. 26:1994;335-346.
27. Robbins T.W., Granon S., Muir J.L., Durantou F., Harrison A., Everitt B.J. Neural systems underlying arousal and attention. Implications for drug abuse. Ann. N.Y. Acad. Sci. 846:1998;222-237.
28. Schindler C.W., Tella S.R., Goldberg S.R. Adrenoceptor mechanisms in the cardiovascular effects of cocaine in conscious squirrel monkeys. Life Sci. 51:1992;653-660.
29. Schindler C.W., Tella S.R., Erzouki H.K., Goldberg S.R. Pharmacological mechanisms in cocaine's cardiovascular effects. Drug Alcohol Depend. 37:1995;183-191.
30. Sofuoglu M., Brown S., Babb D., Pentel P.R., Hatsukami D.K. Effects of labetalol on the subjective and physiological effects of smoked cocaine in humans. Pharmacol. Biochem. Behav. 1999a;. in press.
31. Sofuoglu M., Pentel P.R., Bliss R.L., Goldman A., Hatsukami D.K. Effects of phenytoin on cocaine self-administration in humans. Drug Alcohol Depend. 53:1999b;273-275.
32. Spealman R.D. Noradrenergic involvement in the discriminative stimulus effects of cocaine in squirrel monkeys. J. Pharmacol. Exp. Ther. 275:1995;53-62.
33. Tham T.C., Guy S., McDermott B.J., Shanks R.G., Riddell J.G. The dose dependency of the alpha- and beta-adrenoceptor antagonist activity of carvedilol in man. Br. J. Clin. Pharmacol. 40:1995;19-23.